Companies / Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

OTC: ATXICIK 1644963BAY HARBOR ISLANDS, FL

Financials · FY2025

Revenue$1.40M
Net income$-2.95M
Total debt—
Cash$1.94M
Diluted EPS$-0.22
Shares outstanding3.3M

Ownership

3.3M shares outstanding · as of Aug 4, 2026
13.3%10%+ / strategic
Ownership
10%+ / strategic13.35%439,733
Public float86.65%2,855,234

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Fortress Biotech, Inc.10% owner
13.35%439,733

Institutional holders 0

HolderValue% of shares
No institutional holders on file.
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Fortress Biotech, Inc.
10% owner
GrantCOMMON STOCK, PAR VALUE $0.0001$0+111K
+33.85%
439,733
13.35% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ikarian Capital, LLCPassive13G/A———